secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMV Pharmaceuticals, Inc. (PMVP)
CIK:        0001699382
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001193125-22-168285
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PMV Pharma stockholders re-elect Levine and Baum, approve say-on-pay and one-year frequency, ratify EY
--------------------------------------------------------------------------------

- Arnold Levine elected as Class II director with 29,469,991 FOR votes; Charles Baum with 29,134,747 FOR.
- Non-binding say-on-pay approved: 32,962,908 FOR, 872,088 AGAINST.
- Stockholders favored one-year frequency for future advisory votes on executive compensation (33,827,318 FOR one year).
- Ernst & Young ratified as independent auditor for FY2022: 35,746,657 FOR, 4,223 AGAINST, 451 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699382/000119312522168285/0001193125-22-168285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699382/000119312522168285/d274679d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-168285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer